Clinical Trials Directory

Trials / Completed

CompletedNCT02511522

Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases

Phase III Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
Canadian Cancer Trials Group · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to see whether one dose of palliative radiation therapy directed to the liver in combination with standard BSC might help to reduce liver pain/discomfort due to cancer when compared to getting standard BSC alone.

Detailed description

The standard treatment for liver cancer pain or discomfort like yours is known as best supportive care (BSC) and includes pain-relieving medicines called analgesics. This type of treatment can help in some cases; however, some analgesics require a healthy liver to work properly. This means that there are many patients who have a hard time managing their liver cancer pain/discomfort with BSC alone. Sometimes radiation therapy is given in the "palliative" setting meaning it is designed to treat the pain/discomfort and not necessarily to shrink or eliminate the tumour. Palliative radiation therapy is often given when patients have painful bone tumours, but is not yet widely used to treat liver pain/discomfort. Palliative radiation therapy is usually given in smaller amounts and less frequently than other kinds of radiation therapy.

Conditions

Interventions

TypeNameDescription
OTHERBest Supportive CareIncluding analgesics, palliative care and/or pain specialist assessment as needed
RADIATIONPalliative Radiation Therapy8 Gy in 1 fraction in whole liver or near whole liver. Including anti-emetic pre-medications

Timeline

Start date
2015-12-11
Primary completion
2022-10-26
Completion
2024-10-02
First posted
2015-07-30
Last updated
2024-10-23
Results posted
2024-09-23

Locations

7 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT02511522. Inclusion in this directory is not an endorsement.